AstraZeneca to invest $820 million Canadian in its Ontario global hub
AstraZeneca has announced an investment of CAD$820 million (US$570 million) in its manufacturing facility in ...
Breaking News » AstraZeneca
Explore news about AstraZeneca on Vitals Today: innovative pharmaceutical treatments, research and developments for health
AstraZeneca has announced an investment of CAD$820 million (US$570 million) in its manufacturing facility in ...
AstraZeneca, together with Kunsen, has presented the “EOS Phenotyping Challenge”, an initiative to develop practical tools to optimize the diagnosis ...
The U.S. Food and Drug Administration (FDA) has approved AstraZeneca's Imfinzi (durvalumab). It is the first treatment for ...
AstraZeneca has announced that its drug Tagrisso (osimertinib) has received a recommendation for approval in the European Union (EU) from the Food and Drug Administration (FDA).
AstraZeneca has announced a $3.5 billion equity investment in the US to expand its vaccine portfolio.
Fasenra, developed by AstraZeneca, has received EU approval as an add-on treatment for adults with recurrent EGPA...
© 2024 Vitals Today - all rights reserved
To deliver the best experiences, we use technologies such as cookies to store and/or access device information. Accepting these technologies will allow us to process data such as browsing behavior or unique identifiers on this site. Not accepting or withdrawing consent may negatively impact certain features and functionality.
© 2024 Vitals Today - all rights reserved